J&J Medical Connect
Pulmonary Hypertension
Pulmonary Hypertension

Congress Materials – International Society for Heart & Lung Transplantation (ISHLT 2024)

 

2024 International Society for Heart & Lung Transplantation | Apr 10-13 | Prague, Czech Republic

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses.  Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

 

Survival in Pulmonary Arterial Hypertension for 669 Patients Treated with Selexipag in Clinical Practice: Insights From EXPOSURE

Stefan Söderberg, Pilar Escribano-Subias, Ciara O’Donovan, Audrey Muller, Martina Fontana, Tobias J Lange, Sean Gaine

View presentation slides

 

Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.